Stock Events

Stock Events

Neurobiological Technologies 

$0
3
+$0+0% Tuesday 20:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
200
Avg. Volume
0
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 12
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

6NovExpected
Q1 2007
Q2 2007
Q3 2007
Q4 2007
Q1 2008
Q2 2008
Q3 2008
-1.05
-0.73
-0.42
-0.1
Expected EPS
-0.16
Actual EPS
-0.1

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NTII. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen focuses on neurodegenerative diseases, directly competing in the neurological treatment space similar to NTII.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly has a strong portfolio in neurology and psychiatric conditions, overlapping with NTII's focus areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer has significant investments in treatments for neurological disorders, making it a direct competitor.
Merck
MRK
Mkt Cap214.76B
Merck operates in the neurology sector, particularly in the development of treatments for conditions like Alzheimer's, similar to NTII's interests.
Novartis
NVS
Mkt Cap237.61B
Novartis offers several products for neurological conditions, competing in the same market as NTII.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences has expanded into the neurology space, positioning it as a competitor in the neurological treatment market.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie has a growing focus on neurological diseases, including Parkinson’s and Alzheimer’s, directly competing with NTII.
AMGEN
AMGN
Mkt Cap160.66B
Amgen has research initiatives in neurodegenerative diseases, aligning it as a competitor to NTII.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical specializes in generic and specialty medicines, including treatments for neurological conditions, competing with NTII.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, is involved in developing treatments for neurological disorders, competing with NTII.

About

Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
Show more...
CEO
Mr. John B. Stuppin
Employees
4
Country
US
ISIN
US64124W3043

Listings

OTC Link
US
NTII

0 Comments

Share your thoughts

FAQ

What is Neurobiological Technologies stock price today?▼
The current price of NTII is $0 USD — it has increased by +0% in the past 24 hours. Watch Neurobiological Technologies stock price performance more closely on the chart.
What is Neurobiological Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neurobiological Technologies stocks are traded under the ticker NTII.
What were Neurobiological Technologies earnings last quarter?▼
NTII earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.16 USD resulting in a +37.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
Does Neurobiological Technologies pay dividends?▼
Yes, NTII dividends are paid en. The last dividend per share was 0.05 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Neurobiological Technologies have?▼
As of April 01, 2026, the company has 4 employees.
In which sector is Neurobiological Technologies located?▼
Neurobiological Technologies operates in the Health Care sector.
When did Neurobiological Technologies complete a stock split?▼
The last stock split for Neurobiological Technologies was on September 17, 2007 with a ratio of 1:7.
Where is Neurobiological Technologies headquartered?▼
Neurobiological Technologies is headquartered in EmeryVille, US.